Literature DB >> 3315609

Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex in a district hospital. Tolerance data.

D A Chamberlain1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3315609     DOI： 10.2165/00003495-198700333-00054

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  1 in total

1.  Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.

Authors:  S Ikram; S Lewis; C Bucknall; I Sram; N Thomas; R Vincent; D Chamberlain
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-27
  1 in total
  2 in total

1.  An interim report of the efficacy and safety of anisoylated plasminogen streptokinase activator complex (APSAC).

Authors:  E S Johnson; R J Cregeen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 2.  Comparative tolerability profiles of thrombolytic agents. A review.

Authors:  K S Woo; H D White
Journal:  Drug Saf       Date:  1993-01       Impact factor: 5.606
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.